SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3shm'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S3Z_B_RIOB501_0 (AMINOGLYCOSIDE 6'-N-ACETYLTRANSFERA SE)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 8	TYR A 414 GLU A 417 VAL A 419 TRP A 619	None	1.25A	1s3zA-3shmA: undetectable 1s3zB-3shmA: undetectable	1s3zA-3shmA: 14.26 1s3zB-3shmA: 14.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_W_CHDW4060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.91A	1v54N-3shmA: undetectable 1v54W-3shmA: undetectable	1v54N-3shmA: 22.63 1v54W-3shmA: 8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YC2_E_NCAE509_0 (NAD-DEPENDENT DEACETYLASE 2)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 6	LYS A 567 ASP A 529 GLU A 575 LYS A 528	None	1.44A	1yc2A-3shmA: undetectable 1yc2B-3shmA: undetectable 1yc2E-3shmA: undetectable	1yc2A-3shmA: 18.02 1yc2B-3shmA: 18.02 1yc2E-3shmA: 18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Z35_A_2FAA300_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	5 / 10	GLY A 637 THR A 729 VAL A 612 GLU A 563 SER A 632	None	1.22A	1z35A-3shmA: undetectable	1z35A-3shmA: 17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_MTLA870_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 391 ASN A 382 GLN A 386 PHE A 274	None	1.19A	1zzuA-3shmA: undetectable	1zzuA-3shmA: 21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_MTLB871_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 8	SER A 391 ASN A 382 GLN A 386 PHE A 274	None	1.21A	1zzuB-3shmA: undetectable	1zzuB-3shmA: 21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.91A	2dyrN-3shmA: undetectable 2dyrW-3shmA: undetectable	2dyrN-3shmA: 22.63 2dyrW-3shmA: 8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VQY_A_PARA1201_2 (AAC(6')-IB)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	3 / 3	TRP A 280 GLN A 646 TRP A 247	None	1.29A	2vqyA-3shmA: undetectable	2vqyA-3shmA: 16.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.93A	3ag3A-3shmA: undetectable 3ag3J-3shmA: undetectable	3ag3A-3shmA: 22.63 3ag3J-3shmA: 8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_W_CHDW1059_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.93A	3asnN-3shmA: undetectable 3asnW-3shmA: undetectable	3asnN-3shmA: 22.63 3asnW-3shmA: 8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3LN1_D_CELD682_2 (PROSTAGLANDIN G/H SYNTHASE 2)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 5	ARG A 730 LEU A 300 ILE A 618 PHE A 288	None	1.27A	3ln1D-3shmA: undetectable	3ln1D-3shmA: 21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TTR_A_LQZA90_1 (LACTOTRANSFERRIN)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	3 / 3	PRO A 279 THR A 278 LEU A 648	None	0.63A	3ttrA-3shmA: undetectable	3ttrA-3shmA: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRK_D_CAMD502_0 (CAMPHOR 5-MONOOXYGENASE)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 5	PHE A 292 LEU A 687 GLY A 306 VAL A 612	None	1.08A	3wrkD-3shmA: undetectable	3wrkD-3shmA: 20.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E7B_C_ACTC513_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	3 / 3	TYR A 425 HIS A 427 ARG A 734	None	0.83A	4e7bC-3shmA: undetectable	4e7bC-3shmA: 19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4M2V_A_BZ1A302_1 (CARBONIC ANHYDRASE 2)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	5 / 12	LEU A 355 GLN A 646 VAL A 354 GLY A 361 THR A 278	None	0.88A	4m2vA-3shmA: undetectable	4m2vA-3shmA: 18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O2B_B_LOCB503_1 (TUBULIN ALPHA-1B CHAIN TUBULIN BETA-2B CHAIN)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	3 / 3	SER A 385 ALA A 387 VAL A 388	None	0.57A	4o2bA-3shmA: undetectable	4o2bA-3shmA: 20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_2 (BETA-LACTAMASE CTX-M-14)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	3 / 3	CYH A 290 PRO A 617 ASP A 284	None	0.97A	4pm5A-3shmA: undetectable	4pm5A-3shmA: 17.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Y_A_EF2A151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.42A	4v2yA-3shmA: undetectable	4v2yA-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Y_C_EF2C151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.49A	4v2yC-3shmA: undetectable	4v2yC-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_A_Y70A151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.45A	4v2zA-3shmA: undetectable	4v2zA-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_B_Y70B151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.40A	4v2zB-3shmA: undetectable	4v2zB-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V2Z_C_Y70C151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.46A	4v2zC-3shmA: undetectable	4v2zC-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V30_A_LVYA151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.44A	4v30A-3shmA: undetectable	4v30A-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V30_B_LVYB151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 8	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.32A	4v30B-3shmA: undetectable	4v30B-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4G_A_IPHA903_0 (PROTEIN ARGONAUTE-2)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 6	LEU A 351 TYR A 353 PRO A 352 TYR A 376	None	1.28A	4z4gA-3shmA: undetectable	4z4gA-3shmA: 19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMH_A_EF2A151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.49A	5amhA-3shmA: undetectable	5amhA-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMI_A_EF2A151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.43A	5amiA-3shmA: undetectable	5amiA-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMJ_B_EF2B151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.41A	5amjB-3shmA: undetectable	5amjB-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AMK_B_EF2B151_1 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.38A	5amkB-3shmA: undetectable	5amkB-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HSW_A_ACTA501_0 (ORF 37)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 5	SER A 262 SER A 261 SER A 385 SER A 264	None	1.45A	5hswA-3shmA: undetectable	5hswA-3shmA: 21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NNA_C_BZMC301_0 (ISATIN HYDROLASE A)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	5 / 12	HIS A 291 TRP A 685 PRO A 633 GLY A 616 GLY A 636	None	1.20A	5nnaC-3shmA: undetectable	5nnaC-3shmA: 19.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_A_EF2A202_0 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.44A	5oh1A-3shmA: undetectable	5oh1A-3shmA: 7.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH1_B_EF2B202_0 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.38A	5oh1B-3shmA: undetectable	5oh1B-3shmA: 7.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH3_A_9V2A202_0 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.44A	5oh3A-3shmA: undetectable	5oh3A-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OH3_B_9V2B202_0 (CEREBLON ISOFORM 4)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	PRO A 309 PHE A 638 TRP A 619 TYR A 353	None	1.42A	5oh3B-3shmA: undetectable	5oh3B-3shmA: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH8_A_ACTA302_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	3 / 3	CYH A 483 MET A 524 ASN A 570	None	1.04A	5qh8A-3shmA: undetectable	5qh8A-3shmA: 16.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_A_ACTA309_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 4	LEU A 379 GLY A 275 SER A 261 SER A 262	None	1.16A	5uunA-3shmA: undetectable	5uunA-3shmA: 20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UUN_B_ACTB306_0 (GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 4	LEU A 379 GLY A 275 SER A 261 SER A 262	None	1.13A	5uunB-3shmA: undetectable	5uunB-3shmA: 20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.82A	5xdqN-3shmA: undetectable 5xdqW-3shmA: undetectable	5xdqN-3shmA: 22.63 5xdqW-3shmA: 8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 8	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.80A	5xdxN-3shmA: undetectable 5xdxW-3shmA: undetectable	5xdxN-3shmA: 22.63 5xdxW-3shmA: 8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DWN_C_AQ4C602_0 (CYTOCHROME P450 1A1)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	5 / 12	SER A 675 PHE A 283 GLY A 281 ILE A 319 LEU A 316	None	1.06A	6dwnC-3shmA: undetectable	6dwnC-3shmA: 10.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NJ9_K_SAMK500_0 (HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	5 / 12	GLY A 616 GLY A 637 ALA A 620 PHE A 416 PHE A 307	None	0.97A	6nj9K-3shmA: undetectable	6nj9K-3shmA: 19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMF_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 7	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.97A	6nmfA-3shmA: undetectable 6nmfJ-3shmA: undetectable	6nmfA-3shmA: 22.63 6nmfJ-3shmA: 8.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3shm	CAPSID PROTEIN VP1 (Adeno-associated dependoparvoviru s A)	4 / 5	ILE A 373 LEU A 249 ARG A 245 LEU A 316	None	0.90A	6nmpN-3shmA: undetectable 6nmpW-3shmA: undetectable	6nmpN-3shmA: 22.63 6nmpW-3shmA: 8.37

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1S3Z_B_RIOB501_0","AMINOGLYCOSIDE 6'-N-ACETYLTRANSFERASE","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"TYR A 414;GLU A 417;VAL A 419;TRP A 619","None","1.25A","1s3zA-3shmA:undetectable;1s3zB-3shmA:undetectable","1s3zA-3shmA:14.26;1s3zB-3shmA:14.26"],["1V54_W_CHDW4060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.91A","1v54N-3shmA:undetectable;1v54W-3shmA:undetectable","1v54N-3shmA:22.63;1v54W-3shmA:8.37"],["1YC2_E_NCAE509_0","NAD-DEPENDENT DEACETYLASE 2","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"LYS A 567;ASP A 529;GLU A 575;LYS A 528","None","1.44A","1yc2A-3shmA:undetectable;1yc2B-3shmA:undetectable;1yc2E-3shmA:undetectable","1yc2A-3shmA:18.02;1yc2B-3shmA:18.02;1yc2E-3shmA:18.02"],["1Z35_A_2FAA300_1","PURINE NUCLEOSIDE PHOSPHORYLASE","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",5,"GLY A 637;THR A 729;VAL A 612;GLU A 563;SER A 632","None","1.22A","1z35A-3shmA:undetectable","1z35A-3shmA:17.76"],["1ZZU_A_MTLA870_0","NITRIC-OXIDE SYNTHASE, BRAIN","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"SER A 391;ASN A 382;GLN A 386;PHE A 274","None","1.19A","1zzuA-3shmA:undetectable","1zzuA-3shmA:21.20"],["1ZZU_B_MTLB871_0","NITRIC-OXIDE SYNTHASE, BRAIN","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"SER A 391;ASN A 382;GLN A 386;PHE A 274","None","1.21A","1zzuB-3shmA:undetectable","1zzuB-3shmA:21.20"],["2DYR_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.91A","2dyrN-3shmA:undetectable;2dyrW-3shmA:undetectable","2dyrN-3shmA:22.63;2dyrW-3shmA:8.37"],["2VQY_A_PARA1201_2","AAC(6')-IB","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",3,"TRP A 280;GLN A 646;TRP A 247","None","1.29A","2vqyA-3shmA:undetectable","2vqyA-3shmA:16.83"],["3AG3_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.93A","3ag3A-3shmA:undetectable;3ag3J-3shmA:undetectable","3ag3A-3shmA:22.63;3ag3J-3shmA:8.37"],["3ASN_W_CHDW1059_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.93A","3asnN-3shmA:undetectable;3asnW-3shmA:undetectable","3asnN-3shmA:22.63;3asnW-3shmA:8.37"],["3LN1_D_CELD682_2","PROSTAGLANDIN G\/H SYNTHASE 2","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ARG A 730;LEU A 300;ILE A 618;PHE A 288","None","1.27A","3ln1D-3shmA:undetectable","3ln1D-3shmA:21.79"],["3TTR_A_LQZA90_1","LACTOTRANSFERRIN","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",3,"PRO A 279;THR A 278;LEU A 648","None","0.63A","3ttrA-3shmA:undetectable","3ttrA-3shmA:20.83"],["3WRK_D_CAMD502_0","CAMPHOR 5-MONOOXYGENASE","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PHE A 292;LEU A 687;GLY A 306;VAL A 612","None","1.08A","3wrkD-3shmA:undetectable","3wrkD-3shmA:20.44"],["4E7B_C_ACTC513_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",3,"TYR A 425;HIS A 427;ARG A 734","None","0.83A","4e7bC-3shmA:undetectable","4e7bC-3shmA:19.48"],["4M2V_A_BZ1A302_1","CARBONIC ANHYDRASE 2","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",5,"LEU A 355;GLN A 646;VAL A 354;GLY A 361;THR A 278","None","0.88A","4m2vA-3shmA:undetectable","4m2vA-3shmA:18.02"],["4O2B_B_LOCB503_1","TUBULIN ALPHA-1B CHAIN;TUBULIN BETA-2B CHAIN","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",3,"SER A 385;ALA A 387;VAL A 388","None","0.57A","4o2bA-3shmA:undetectable","4o2bA-3shmA:20.75"],["4PM5_A_CE3A301_2","BETA-LACTAMASE CTX-M-14","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",3,"CYH A 290;PRO A 617;ASP A 284","None","0.97A","4pm5A-3shmA:undetectable","4pm5A-3shmA:17.56"],["4V2Y_A_EF2A151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.42A","4v2yA-3shmA:undetectable","4v2yA-3shmA:13.50"],["4V2Y_C_EF2C151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.49A","4v2yC-3shmA:undetectable","4v2yC-3shmA:13.50"],["4V2Z_A_Y70A151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.45A","4v2zA-3shmA:undetectable","4v2zA-3shmA:13.50"],["4V2Z_B_Y70B151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.40A","4v2zB-3shmA:undetectable","4v2zB-3shmA:13.50"],["4V2Z_C_Y70C151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.46A","4v2zC-3shmA:undetectable","4v2zC-3shmA:13.50"],["4V30_A_LVYA151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.44A","4v30A-3shmA:undetectable","4v30A-3shmA:13.50"],["4V30_B_LVYB151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.32A","4v30B-3shmA:undetectable","4v30B-3shmA:13.50"],["4Z4G_A_IPHA903_0","PROTEIN ARGONAUTE-2","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"LEU A 351;TYR A 353;PRO A 352;TYR A 376","None","1.28A","4z4gA-3shmA:undetectable","4z4gA-3shmA:19.07"],["5AMH_A_EF2A151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.49A","5amhA-3shmA:undetectable","5amhA-3shmA:13.50"],["5AMI_A_EF2A151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.43A","5amiA-3shmA:undetectable","5amiA-3shmA:13.50"],["5AMJ_B_EF2B151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.41A","5amjB-3shmA:undetectable","5amjB-3shmA:13.50"],["5AMK_B_EF2B151_1","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.38A","5amkB-3shmA:undetectable","5amkB-3shmA:13.50"],["5HSW_A_ACTA501_0","ORF 37","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"SER A 262;SER A 261;SER A 385;SER A 264","None","1.45A","5hswA-3shmA:undetectable","5hswA-3shmA:21.58"],["5NNA_C_BZMC301_0","ISATIN HYDROLASE A","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",5,"HIS A 291;TRP A 685;PRO A 633;GLY A 616;GLY A 636","None","1.20A","5nnaC-3shmA:undetectable","5nnaC-3shmA:19.09"],["5OH1_A_EF2A202_0","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.44A","5oh1A-3shmA:undetectable","5oh1A-3shmA:7.57"],["5OH1_B_EF2B202_0","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.38A","5oh1B-3shmA:undetectable","5oh1B-3shmA:7.57"],["5OH3_A_9V2A202_0","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.44A","5oh3A-3shmA:undetectable","5oh3A-3shmA:13.50"],["5OH3_B_9V2B202_0","CEREBLON ISOFORM 4","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"PRO A 309;PHE A 638;TRP A 619;TYR A 353","None","1.42A","5oh3B-3shmA:undetectable","5oh3B-3shmA:13.50"],["5QH8_A_ACTA302_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",3,"CYH A 483;MET A 524;ASN A 570","None","1.04A","5qh8A-3shmA:undetectable","5qh8A-3shmA:16.17"],["5UUN_A_ACTA309_0","GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"LEU A 379;GLY A 275;SER A 261;SER A 262","None","1.16A","5uunA-3shmA:undetectable","5uunA-3shmA:20.29"],["5UUN_B_ACTB306_0","GLUTATHIONE S-TRANSFERASE-LIKE PROTEIN","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"LEU A 379;GLY A 275;SER A 261;SER A 262","None","1.13A","5uunB-3shmA:undetectable","5uunB-3shmA:20.29"],["5XDQ_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.82A","5xdqN-3shmA:undetectable;5xdqW-3shmA:undetectable","5xdqN-3shmA:22.63;5xdqW-3shmA:8.37"],["5XDX_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.80A","5xdxN-3shmA:undetectable;5xdxW-3shmA:undetectable","5xdxN-3shmA:22.63;5xdxW-3shmA:8.37"],["6DWN_C_AQ4C602_0","CYTOCHROME P450 1A1","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",5,"SER A 675;PHE A 283;GLY A 281;ILE A 319;LEU A 316","None","1.06A","6dwnC-3shmA:undetectable","6dwnC-3shmA:10.28"],["6NJ9_K_SAMK500_0","HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-79 SPECIFIC","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",5,"GLY A 616;GLY A 637;ALA A 620;PHE A 416;PHE A 307","None","0.97A","6nj9K-3shmA:undetectable","6nj9K-3shmA:19.78"],["6NMF_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.97A","6nmfA-3shmA:undetectable;6nmfJ-3shmA:undetectable","6nmfA-3shmA:22.63;6nmfJ-3shmA:8.37"],["6NMP_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3shm","CAPSID PROTEIN VP1","Adeno-associated dependoparvovirus A",4,"ILE A 373;LEU A 249;ARG A 245;LEU A 316","None","0.90A","6nmpN-3shmA:undetectable;6nmpW-3shmA:undetectable","6nmpN-3shmA:22.63;6nmpW-3shmA:8.37"]]